[Immunological status of onchocerciasis patients and its changes during diethylcarbamazine and suramin treatment (a review of the literature)].
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D000936:Antigen-Antibody Complex / Q000032:analysis; D004049:Diethylcarbamazine / Q000009:adverse effects / Q000276:immunology*; D004361:Drug Tolerance; D006801:Humans; D007108:Immune Tolerance / Q000187:drug effects; D007111:Immunity, Cellular / Q000187:drug effects; D007136:Immunoglobulins / Q000032:analysis; D009855:Onchocerciasis / Q000188:drug therapy / Q000276:immunology*; D013498:Suramin / Q000009:adverse effects / Q000276:immunology*; D013997:Time Factors
D000936:Antigen-Antibody Complex; D007136:Immunoglobulins; D013498:Suramin; D004049:Diethylcarbamazine
Immunologicheskiĭ status u bol'nykh onkhotserkozom i ego izmeneniia pri lechenii diétilkarbamazinom (DEK) i suraminom (obzor literatury).